Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Global and Regional Estimates and Projections of Diabetes-Related Health Expenditure: Results From the International Diabetes Federation Diabetes Atlas, 9Th Edition Publisher Pubmed



Williams R1 ; Karuranga S2 ; Malanda B2 ; Saeedi P2 ; Basit A3 ; Besancon S4 ; Bommer C5 ; Esteghamati A6 ; Ogurtsova K7 ; Zhang P8 ; Colagiuri S9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Diabetes Research Unit Cymru, Swansea University, Swansea, United Kingdom
  2. 2. International Diabetes Federation, Brussels, Belgium
  3. 3. Baqai Institute of Diabetology and Endocrinology (BIDE), Pakistan
  4. 4. ONG Sante Diabete (SD), France
  5. 5. University of Goettingen, Germany
  6. 6. Tehran University of Medical Sciences, Iran
  7. 7. Institute for Health Services Research and Health Economics, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany
  8. 8. Centers for Disease Control, United States
  9. 9. The University of Sydney, School of Medicine, Australia

Source: Diabetes Research and Clinical Practice Published:2020


Abstract

Aims: Diabetes and its complications have a significant economic impact on individuals and their families, health systems and national economies. Methods: The direct health expenditure of diabetes was calculated relying on the following inputs: diagnosed and undiagnosed diabetes prevalence estimates, United Nations population estimates, World Health Organization health expenditure per capita and ratios of health expenditure for people with diabetes compared to people without diabetes. Results: The estimated global direct health expenditure on diabetes in 2019 is USD 760 billion and is expected to grow to a projected USD 825 billion by 2030 and USD 845 billion by 2045. There is a wide variation in annual health expenditures on diabetes. The United States of America has the highest estimated expenditure with USD 294.6 billion, followed by China and Brazil, with USD 109.0 billion and USD 52.3 billion, respectively. The age group with the largest annual diabetes-related health expenditure is 60–69 years with USD 177.7 billion, followed by 50–59 years, and 70–79 years with USD 173.0 billion and USD 171.5 billion, respectively. Slightly higher diabetes-related health expenditure is seen in women than in men (USD 382.6 billion vs. USD 377.6 billion, respectively). The same difference is expected to be present in 2030 and 2045. Conclusions: There were large disparities between high-, middle- and low-income countries with total health expenditures in high-income countries being over 300 times those in low-income countries. The ratio for annual direct health expenditure per person between these groups of countries is more than 38-fold. © 2020 Elsevier B.V.
Related Docs
1. National Innovation System for Diabetes and Metabolic Disorders Can Promote Biomedical Research Accountability; a Literature Review and Designing a Conceptual Framework, Journal of Diabetes and Metabolic Disorders (2021)
2. Economic Burden of Type 2 Diabetes in Iran in 2022, BMC Public Health (2025)
3. The Diabetes Cascade of Care Through the 14 Years in Iran: Findings of Nationwide Steps Surveys 2007–2021, Journal of Diabetes and Metabolic Disorders (2023)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (2)
Afshin Ostovar (1)